OBJECTIVES: In response to increased pressure to contain costs and optimize patient outcomes, hospitals have implemented standardized decision-making processes utilizing value analysis committees (VACs). In 2012, 64% of hospitals reported using some form of VAC. The objective of this analysis was to quantify the adoption of VAC, the product features considered impactful by VAC, timing of review and evidence requirements.  METHODS: Qualitative interviews (n=40) and quantitative online survey (n=76) were conducted with C-suite executives, purchasers, and clinician leads in the second half of 2014. Research participants were drawn from across the US, from a diverse selection of hospitals, including large/small, rural/urban and profit/non-profit. Outcomes of the research included adoption of VAC, triggers for VAC review, timing of review process, evidence requirements and implications for medical device companies. RESULTS: